UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049788
Receipt number R000056613
Scientific Title The effects of feeding camellia oil made in Goto Islands on skin condition
Date of disclosure of the study information 2023/01/21
Last modified on 2023/05/17 09:21:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of feeding camellia oil made in Goto Islands on skin condition

Acronym

The effects of feeding camellia oil on skin condition

Scientific Title

The effects of feeding camellia oil made in Goto Islands on skin condition

Scientific Title:Acronym

The effects of feeding camellia oil on skin condition

Region

Japan


Condition

Condition

Healthy adult female

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of feeding camellia oil on skin condition in healthy adult women

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Stratum corneum water content

Key secondary outcomes

Transepidermal water loss
skin elasticity
amount of sebum
amount of sebum recovery


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

To take oil 10g/day without Camellia oil for 4 weeks

Interventions/Control_2

To take Camellia oil 10g/day for 4 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

75 years-old >

Gender

Female

Key inclusion criteria

1) Persons with skin problems
2) persons who con moderate their intake of fatty foods

Key exclusion criteria

1) Persons who have a smoking habit
2) persons with a history of serious liver disorder, renal disorder, or heart disease
3) persons with a history of other serious illnesses
4) persons who have received treatment such as immunosuppression within the past 3 months
5) persons who like to eat fatty foods
6) persons who may have an allergic reaction to the test product ingredients
7) persons with chronic skin diseases such as atopic dermatitis
8) persons with scars, warts, pimples, permanent makeup, burns, etc. that affect the evaluation measurement on the face
9) persons who have a history of allergies to cosmetics
10) persons receiving hormone replacement therapy
11) persons who have experience of cosmetic medicine that affects the test site
12) persons who have difficulty maintaining lifestyle habits (eating, exercising, sleeping, skin care, etc.)
13) persons who have difficulty filling in the subject diary
14) pregnant, breastfeeding,or possibly pregnant
15) persons who are participating in other clinical trials at the start of this trial
16) individuals or family members who work for a company that develops, manufactures, or sells food

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kazunari
Middle name
Last name Tanaka

Organization

Univercity of Nagasaki

Division name

Regional Partnership Center

Zip code

8512195

Address

1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195

TEL

0958135216

Email

katanaka@sun.ac.jp


Public contact

Name of contact person

1st name Shirou
Middle name
Last name Matsumura

Organization

Univercity of Nagasaki

Division name

Regional Partner Center

Zip code

8512195

Address

1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195

TEL

0958135216

Homepage URL


Email

katanaka@sun.ac.jp


Sponsor or person

Institute

Univercity of Nagasaki

Institute

Department

Personal name



Funding Source

Organization

MTG Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Univercity of Nagasaki

Address

1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195

Tel

0958135216

Email

katanaka@sun.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 10 Month 28 Day

Date of IRB

2022 Year 11 Month 22 Day

Anticipated trial start date

2023 Year 01 Month 15 Day

Last follow-up date

2023 Year 07 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 12 Month 15 Day

Last modified on

2023 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056613